Sun-Taro Merger Nearing Completion As Shareholders Vote Yes

Sun Pharma Shares Thoughts On Generic GLP-1s, Mohali Plant, And FY2024 Results

Sun Pharma will finally merge with Taro as a single company, after failed attempts to absorb the firm over a decade ago. Also, the firm hints about its upcoming generic portfolio, including GLP-1 products, as well as increasing investment into its specialty business.

Shaking hands illustration
• Source: Shutterstock

More from Deals

More from Business